Source: Annual Congress 2008 - Metabolic and sex-related aspects of obstructive sleep apnoea
Disease area: Sleep and breathing disorders



Rating:

Share or cite this content

Citations should be made in the following way:
M. Pallayova, V. Donic, Z. Tomori (Kosice, Slovakia). Severe sleep apnea, type 2 diabetes and beneficial effects of CPAP on nocturnal glucose control. Eur Respir J 2008; 32: Suppl. 52, 852

Member's Comments

No comment yet.

Related content which might interest you: Impact of obstructive sleep apnoea (OSA) on glucose metabolism Source: Annual Congress 2007 - Cardiovascular and metabolic consequences of obstructive sleep apnoea: early changes, biomarkers and impact of treatment Year: 2007 A study of insulin resistance in moderate to severe obstructive sleep apnea in non diabetics and its response to nasal CPAP treatment Source: Annual Congress 2011 - Cardiometabolic and neurocognitive changes in obstructive sleep apnoea Year: 2011 Insulin resistance and patterns of continuous glucose monitoring in sleep apnoea patients: relationship with nocturnal hypoxemia and CPAP therapy Source: Annual Congress 2007 - Metabolic consequences of obstructive sleep apnoea Year: 2007 The impact of obstructive sleep apnea (OSA) severity on type 2 diabetes prevalence Source: Sleep and Breathing Conference 2021 Year: 2021 Should obstructive sleep apnoea be treated regarding the related cardiovascular risk in non sleepy patients? Source: Annual Congress 2006 - Obstructive sleep apnoea and cardiovascular diseases Year: 2006 Treatment with CPAP reduces mortality in patients with obstructive sleep apnoea syndrome within less than 3 years Source: Annual Congress 2006 - Therapeutic effects in obstructive sleep apnoea Year: 2006 Effect of continuous positive airway pressure treatment on hypoadiponectinemia in male patients with obstructive sleep apnea syndrome Source: Annual Congress 2005 - Metabolic control in OSA Year: 2005 The relationship between obstructive sleep apnea hypopnea syndrome and insulin resistance, vascular complications in patients with type 2 diabetes mellitus Source: Annual Congress 2011 - Obstructive sleep apnoea: clinical aspects I Year: 2011 Metabolic disturbances in patients with obstructive sleep apnoea syndrome Source: Eur Respir Rev 2007; 16: 196-202 Year: 2007 Effect of continuous positive airway pressure therapy on metabolic control in patients with morbid obesity and obstructive sleep apnoea Source: Annual Congress 2013 –Burn after reading: inflammation in sleep disordered breathing Year: 2013 Cardiovascular regulation effects of CPAP therapy in obstructive sleep apnea patients with and without hypertension during daytime Source: Annual Congress 2012 - Metabolic and cardiovascular consequences of OSA II Year: 2012 Sleep, sleep-disordered breathing and metabolic consequences Source: Eur Respir J 2009; 34: 243-260 Year: 2009 Nocturnal melatonin plasma levels in patients with OSAS: the effect of CPAP Source: Eur Respir J 2007; 30: 496-500 Year: 2007 Effect of 8 week CPAP therapy on insulin resistance, serum leptin and lipid concentrations among obstructive sleep apnea hypopnea syndrome (OSAS) patients Source: Eur Respir J 2004; 24: Suppl. 48, 330s Year: 2004 Leptin and ghrelin levels in patients with obstructive sleep apnoea: effect of CPAP treatment Source: Eur Respir J 2003; 22: 251-257 Year: 2003 Sibutramine versus continuous positive airway pressure in obese obstructive sleep apnoea patients Source: Eur Respir J 2009; 34: 694 Year: 2009 Effects of CPAP treatment on physical fitness in patients with obstructive sleep apnoea syndrome (OSAS) Source: Eur Respir J 2003; 22: Suppl. 45, 97s Year: 2003 Cardiovascular and metabolic effects of CPAP in obese obstructive sleep apnoea patients Source: Eur Respir J 2008; 31: 223-225 Year: 2008 Effects of a lifestyle intervention in obese obstructive sleep apnoea patients treated with CPAP Source: Annual Congress 2012 - Sleep apnoea: clinical topics Year: 2012 Obstructive sleep apnea Source: Respipedia Article Year: 2017